XinKe Pharma

Beijing Xinke Pharmaceutical Co., Ltd. (Xinke Pharma) is a Chinese pharmaceutical company that specializes in the development and manufacturing of treatments for cardiovascular and cerebrovascular diseases. As a wholly-owned subsidiary of Beijing Beilu Pharmaceutical Co., Ltd., Xinke Pharma is a key player in the domestic market for injectable therapies. Its flagship product, a combination of Ginkgo Leaf Extract and Dipyridamole, is widely prescribed for conditions such as coronary heart disease and cerebral infarction. The company operates advanced GMP-certified production facilities in Beijing and leverages its parent company's extensive distribution network to reach healthcare providers across China. Xinke Pharma's integration into Beilu Pharma has strengthened the group's portfolio in chronic disease management and high-barrier generic medications.